Fatty acid elongation in non-alcoholic steatohepatitis and hepatocellular carcinoma.
about
Utilization of animal models to investigate non-alcoholic steatohepatitis-associated hepatocellular carcinomaHepatocellular carcinoma and non-alcoholic steatohepatitis: The state of playSusceptibility of Different Mouse Wild Type Strains to Develop Diet-Induced NAFLD/AFLD-Associated Liver DiseaseElevated free cholesterol in a p62 overexpression model of non-alcoholic steatohepatitis.Elovl6 is a poor prognostic predictor in breast cancer.Phospholipid profiling identifies acyl chain elongation as a ubiquitous trait and potential target for the treatment of lung squamous cell carcinoma.Hepatic erythropoietin response in cirrhosis. A contemporary review.Acetyl-coenzyme A carboxylase alpha promotion of glucose-mediated fatty acid synthesis enhances survival of hepatocellular carcinoma in mice and patients.The IGF2 mRNA binding protein p62/IGF2BP2-2 induces fatty acid elongation as a critical feature of steatosis.IMP2/p62 induces genomic instability and an aggressive hepatocellular carcinoma phenotype.A distinct function of the retinoblastoma protein in the control of lipid composition identified by lipidomic profiling.Aberrant Lipid Metabolism in Hepatocellular Carcinoma Revealed by Liver Lipidomics.The stearate-to-palmitate ratio modulates endoplasmic reticulum stress and cell apoptosis in non-B non-C hepatoma cells.Hyper-Elongation in Colorectal Cancer Tissue - Cerotic Acid is a Potential Novel Serum Metabolic Marker of Colorectal Malignancies.
P2860
Q26748807-35D9EFBC-AE83-4BC5-BB14-D4FC6B4F5E17Q26764911-15F8B59D-E562-4A51-A55F-FEE9E82D3734Q28551941-D6113E9F-504B-4C44-B254-02075A2CCFF7Q34750585-BE004AC1-A6D6-45D1-9686-823C980EE804Q37002333-B489D013-FB9B-40F8-A408-7523813AE07BQ37022229-FA15C4DC-C615-437B-9E06-C5A1E190B3F4Q38751471-3BBA4D3B-256B-41C5-AC1A-173BA2E58823Q38809565-5ECE5721-E4E3-4C24-A65E-84169D9D5E62Q39896001-5D78EE0A-278A-4983-8039-C05708FF61B6Q40478066-0377F326-7D4B-450C-87AF-F7B177A8B131Q41072298-0B39D7C6-D741-4BE2-8F32-8DD0943C4E98Q49575221-D9A9A41C-155E-46EA-8B2E-B92FFD479182Q50088540-1B45D2DE-7CCF-4CA1-BADA-B0B8D6A1BFA7Q50884851-83AFED28-21BF-497E-88A1-8CB1E7DBB4C4
P2860
Fatty acid elongation in non-alcoholic steatohepatitis and hepatocellular carcinoma.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Fatty acid elongation in non-alcoholic steatohepatitis and hepatocellular carcinoma.
@en
Fatty acid elongation in non-alcoholic steatohepatitis and hepatocellular carcinoma.
@nl
type
label
Fatty acid elongation in non-alcoholic steatohepatitis and hepatocellular carcinoma.
@en
Fatty acid elongation in non-alcoholic steatohepatitis and hepatocellular carcinoma.
@nl
prefLabel
Fatty acid elongation in non-alcoholic steatohepatitis and hepatocellular carcinoma.
@en
Fatty acid elongation in non-alcoholic steatohepatitis and hepatocellular carcinoma.
@nl
P2093
P2860
P50
P356
P1476
Fatty acid elongation in non-alcoholic steatohepatitis and hepatocellular carcinoma.
@en
P2093
Ahmad Barghash
Cristina Cadenas
Frank Lammert
Johannes Haybaeck
Juliane Pokorny
Kathrin Gianmoena
Katja Gemperlein
Rainer M Bohle
Sonja M Kessler
Yvette Simon
P2860
P304
P356
10.3390/IJMS15045762
P407
P577
2014-04-04T00:00:00Z